Rheumatoid Arthritis and Cancer: Does Treatment With Anti-Rheumatic Drug Therapy Increase the Risk of Cancer Among RA Patients?

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

By RheumNow FEATURING Jonathan Kay

June 15, 2021

Feat. M. Zlupko

Cleveland Clinic Rheumatology

West Virginia State Rheumatology Society

J. Bustamante

4 months ago

Keck School of Medicine of USC

E. Taylor-Albert

5 months ago

Cleveland Clinic Rheumatology

11 months ago

Namrata Singh

EADV 2022 Conference Coverage

K. Isoherranen

EADV 2022 Conference Coverage

Xavier Mariette

ACR Convergence 2021 Coverage

A. Strangfeld

Cedars Sinai

A. Kavanaugh, J. Cush

Hospital for Special Surgery

Highlights from ACR Convergence 2023

Cleveland Clinic Rheumatology

C. Calabrese

Cleveland Clinic Rheumatology

L. Calabrese

Login

Login

Join VuMedi

Rheumatoid Arthritis and Cancer: Does Treatment With Anti-Rheumatic Drug Therapy Increase the Risk of Cancer Among RA Patients?

Are your patients with moderate to severe Rheumatoid Arthritis (RA) …

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Recommended

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Update on the New ANA Classification System

Points to Consider When Managing Inflammatory Arthritis with Cancer

Integrative Health Approaches for Optimum Immune Health

​​ACR Convergence 2023 Highlights: People with RA and Long COVID Had…

Disease Modifying Anti-rheumatic Drugs and Lymphoma Risk in Rheumato…

An Overview of Atypical Ulcers

EADV 2022: Microbiota and Biofilms in Hidradenitis Suppurativa

Malignancy Events in the Filgotinib Rheumatoid Arthritis and Ulcerat…

Occurrence of Basal Cell and Squamous Cell Carcinomas of the Skin Un…

Medical Therapy Related Complications in IBD

RWCS 2021 Highlights on Biologics/tsDMARDs: What Are the Commonly Co…

Serological Response to SARS-CoV-2 Vaccination in Patients Treated W…

Steroids, COX-2 Inhibitors & Diagnosis of Musculoskeletal Complaints…

RA & DVT Management: Should RA/DVT Patients Stop JAK Inhibitors? Wha…

ACR Convergence 2023 Highlights: Two-week Break in Methotrexate Trea…

Challenges of Prevention and Treatment of COVID-19 in the Immunocomp…

The Epidemic Long COVID-19: Questions & Implications for Rheumatology

ACR Convergence 2023 Highlights: People with RA and Long COVID Had…